12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers LifeStance Health Gr (NASDAQ:LFST) stock increased by 37.0% to $6.89 during Friday’s pre-market session. The market value…
Calyxt Achieves Phase 1 Milestone In Collaboration Agreement To Develop Alternative To Palm Oil
Calyxt, Inc. (NASDAQ:CLXT), a plant-based synthetic biology company announced today that it has successfully completed the first phase in its research collaboration agreement with a leading global food ingredient
Calyxt Granted 180-Day Extension By Nasdaq To Regain Compliance With Bid Price Rule
Calyxt, Inc (NASDAQ:CLXT) a plant-based synthetic biology focused on engineering sustainable ingredients for customers in the cosmeceutical, nutraceutical and pharmaceutical industries, today announced that the Company
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 236 companies set new 52-week lows.
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Earnings Preview: Calyxt
Calyxt (NASDAQ:CLXT) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement.
Analysts estimate that Calyxt will report an earnings per share (EPS) of $-0.14.
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 528 companies set new 52-week lows.
Calyxt Announced Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients
Calyxt, Inc. (Nasdaq: CLXT) today announced that it has signed an agreement with its first manufacturing partner, Evologic Technologies GmbH, to further develop and scale Calyxt's proprietary Plant Cell Matrix™ (PCM™) technology platform.